Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, February 23, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
LATEST ARTICLES
Latest Pharma-News
FDA approved Innovent Biologic’s Acceptance of NDA submission for Pemigatinib(FGFR1/2/3 inhibitor) in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with...
admin
-
December 2, 2019
0
Latest Pharma-News
The European Commission approved Celltrion’s Remsima SC (infliximab) trials for the treatment of Chron’s disease, ulcerative colitis and rheumatoid arthritis
admin
-
November 30, 2019
0
Latest Pharma-News
EOS imaging receives U.S. FDA 510(k) clearance for EoSedge™ its new generation innovative imaging system , EoSedge in Europe, Canada and Australia
admin
-
November 30, 2019
0
Latest Pharma-News
Y-mAbs Initiates Submission of Biologics License Application to U.S. FDA for naxitamab for the treatment of patients with relapsed/refractory high-risk neuroblastoma
admin
-
November 30, 2019
0
Latest Pharma-News
US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for AstraZeneca’s Imfinzi (durvalumab) for the...
admin
-
November 30, 2019
0
Latest Pharma-News
Collaboration of Bayer and Pharmaron to develop new molecular entities for veterinary medicines
admin
-
November 30, 2019
0
Latest Pharma-News
QIAGEN and DiaSorin receive FDA approval for the LIAISON QuantiFERON-TB Plus Test the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s...
admin
-
November 29, 2019
0
Latest Pharma-News
NICE approves Ibrance via Cancer Drugs Fund in combination with fulvestrant for the treatment of women who have hormone receptor positive (HR+) and HER2-...
admin
-
November 29, 2019
0
Latest Pharma-News
Elsevier acquires 3D4Medical, initiator of world-leading 3D anatomy technology and design
admin
-
November 29, 2019
0
Latest Pharma-News
USFDA Approves Biocon and Mylan’s supplemental Biologics License Application (sBLA) for Pegfilgrastim Drug Substance to be manufactured at Biocon’s new Biologics manufacturing facility
admin
-
November 28, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration orders Puerto Rico fertility clinic to stop manufacturing immediately for significant violations Due to significant violations of FDA...
admin
-
November 28, 2019
0
Latest Pharma-News
IMCD again expands global network with the opening of three Pharma Technical Centres in Asia Pacific in India, Southeast Asia and China and offers...
admin
-
November 28, 2019
0
1
...
151
152
153
...
156
Page 152 of 156
Other
What is Decentralized clinical trials?:Benefits and challenges of implementing DCT
September 23, 2024
Navigating the Job Interview: How to Answer the Question, “Why Are You Changing Jobs?”
September 16, 2023
Big Data Analytics: New Possibilities In The Pharmaceutical Industry
November 19, 2021
Causes, Symptoms And Treatment Of Mesothelioma
October 4, 2021
Load more